We investigated how an inflammation status, here mimicked by inflammatory cytokine IL-1β treatment, affected the proliferation of the breast cancer cell line MCF-7 Figure 1A shows the viability of MCF-7 was increased by the IL-1β treatment both in concentration and over time (p < 0.0005). Here, IL1B is linked to breast carcinoma.